Table 1

Demographic, risk and medical characteristics of n=4055 individuals randomised to the UK Lung Cancer Screening (UKLS) intervention (CT screen) and control (non-screen) trial arms

 Total n=4055
Screen arm (n=2028)Control arm (n=2027)
Male:female ratio1529:499 (3.06:1)1507:520 (2.90:1)
North:south ratio1023:1005 (1.02:1)1023:1004 (1.02:1)
Mean (SD) age, years67.1 (4.1)66.9 (4.1)
Median age, years6767
Median IMD rank*17 37417 704
Mean (SD) LLPv2 score8.87 (5.12)8.83 (4.71)
Median LLPv2 score7.117.35
Never smokers2 (0.1)0 (0%)
Current smokers777 (38.3%)791 (39.0%)
Ex-smokers1249 (61.6%)1236 (61.0%)
Smoking duration 10–19 years†117 (5.8%)116 (5.7%)
Smoking duration 20+ years†1895 (93.4%)1907 (94.1%)
Smoking duration unknown†14 (0.7%)4 (0.2%)
% Asbestos exposed763 (37.6%)763 (37.6%)
% with history of respiratory disease‡1056 (52.1%)1023 (50.5%)
% with history of blood cancer§26 (1.28%)31 (1.53%)
% with history of solid tumour¶378 (18.6%)396 (19.5%)
Total % with family history of lung cancer498 (24.6%)554 (27.3%)
% with family history of lung cancer <60 years215 (10.6%)215 (10.6%)
% with family history of lung cancer >60 years283 (14.0%)339 (16.7%)
Family history of other cancer (not lung)**1026 (50.6%)1019 (50.3%)
  • *Index of Multiple Deprivation (IMD) rank (https://www.gov.uk/government/collections/english-indices-of-deprivation).

  • †All smoking duration figures refer to current and ex-smokers combined.

  • ‡Asthma, bronchitis, TB, pneumonia, COPD or emphysema.

  • §Leukaemia or lymphoma, including Hodgkin's.

  • ¶Cancers of brain, head and neck, oesophagus, breast, colon or ‘other’.

  • **Cancers of brain, head and neck, oesophagus, breast, colon or ‘other’.

  • LLP, Liverpool Lung Project.